BACKGROUND
Nowadays, there is an increasing interest for alternative options in the treatment of inflammatory bowel diseases (IBDs) that combine efficacy and an adequate safety profile.
METHODS
The intestinal anti-inflammatory effects of Serpylli herba, the officinal drug in the European